Michael Daskalakis

Has grant

Assistant Professor, Head of Cellular Therapy Division, Director of autologous Stem Cell Program Inselspital

Inselspital Universitätsspital Bern

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Immunology Immunology professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Michael Daskalakis is an Assistant Professor and the Head of the Cellular Therapy Division at Inselspital Universitätsspital Bern, Switzerland. His research primarily focuses on hematopoietic cell transplantation, cellular therapies, and outcomes following autologous stem cell transplantation. Recent publications include studies on CAR-T cell therapy, stem cell mobilization strategies in myeloma patients, and the implications of clonal hematopoiesis in treatment outcomes.

Recent Grants

Grant: Close

Characterization of Oncogenic Protein Isoforms as Targets for Myelodysplastic Syndromes

Open Date: 2020-01-01

Close Date: 2021-12-01

Grant: Close

Translational study on viral mimicry: Marker for prediction of epigenetic treatment response or prognosis in patients with AML or MDS ? Pilot study funding for PCR analysis of patient samples requested

Open Date: 2019-09-01

Close Date: 2020-08-01

Articles (23)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (13)

Martin Mueller

Associate Professor

Inselspital Universitätsspital Bern

SWITZERLAND

View details

Jens Bauer

Postdoc – Head of Research

Universitätsklinikum Tübingen

GERMANY

View details

Katja Seipel

University Hospital of Bern

SWITZERLAND

View details

Henning Nilius

University of Bern

SWITZERLAND

View details

Jarmila Anna Zdanowicz

University Hospital of Bern

SWITZERLAND

View details

Caroline Arber

Research Group Leader, Attending Physician, Associate Professor

Lausanne University Hospital

SWITZERLAND

View details

Lucia Lopez Corral

Universidad de Salamanca

SPAIN

View details

Naomi A. Porret

Lab Head molecular diagnostics

Inselspital Universitätsspital Bern

SWITZERLAND

View details

Daniel Surbek

Professor and Chairman

University of Bern

SWITZERLAND

View details

Thomas Pabst

SWITZERLAND

View details

Simona Pagliuca

FRANCE

View details

Sophie Schneider

University of Bern

SWITZERLAND

View details

Nina Worel

Medical University of Vienna

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michael Daskalakis

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (23)

Clonal Hematopoiesis and Outcomes After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with AML, Myeloma, and Lymphoma

CAR-T cell manufacturing failures and out-of-specification products in the real-world setting: A survey from the EBMT cellular therapy and immunobiology working party

Comparing stem cell mobilization with chemotherapy and cytokine (G-CSF) versus cytokine alone in myeloma patients (MOCCCA): a randomized phase II, open-label, non-inferiority trial

Gemtuzumab Ozogamicin and Stem Cell Mobilization for Autologous Stem Cell Transplantation in Favorable Risk Acute Myeloid Leukemia

Safety and Efficacy of High-Dose Chemotherapy with TreoMel 200 vs. TreoMel 140 in Acute Myeloid Leukemia Patients Undergoing Autologous Stem Cell Transplantation

Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMT

Daratumumab during Myeloma Induction Therapy Is Associated with Impaired Stem Cell Mobilization and Prolonged Post-Transplant Hematologic Recovery

Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997–2021

Clinical Impact of Single Nucleotide Polymorphism in CD-19 on Treatment Outcome in FMC63-CAR-T Cell Therapy

Efficacy and Safety of High-Dose Chemotherapy with Treosulfan and Melphalan in Multiple Myeloma

CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma

Stem Cell Mobilization with Ixazomib and G-CSF in Patients with Multiple Myeloma

Evaluation of Bortezomib-BeEAM (2BeEAM) as Chemotherapy Regimen Prior to ASCT in Patients with Mantle Cell Lymphoma

BeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom’s Macroglobulinemia

Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome

A Retrospective before and after Assessment of Multidisciplinary Management for Postpartum Hemorrhage

CAR-T Cell Therapy Shows Similar Efficacy and Toxicity in Patients With DLBCL Regardless of CNS Involvement

DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts

“Don’t Add Fuel to the Fire”– Hyperhemolysis Syndrome in a Pregnant Woman with Compound Sickle Cell Disease/β&lt;sup&gt;0&lt;/sup&gt;-Thalassemia: Case Report and Review of the Literature

Organ complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working party

Combining BeEAM with Brentuximab Vedotin for High-Dose Therapy in CD30 Positive Lymphomas before Autologous Transplantation—A Phase I Study

Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma

BeEAM High-Dose Chemotherapy with Polatuzumab (Pola-BeEAM) before ASCT in Patients with DLBCL—A Pilot Study

Collaborators (13)

Martin Mueller

Jens Bauer

Katja Seipel

Henning Nilius

Jarmila Anna Zdanowicz

Caroline Arber

Lucia Lopez Corral

Naomi A. Porret

Daniel Surbek

Thomas Pabst

Simona Pagliuca

Sophie Schneider

Nina Worel

Make your next move.

“Don’t Add Fuel to the Fire”– Hyperhemolysis Syndrome in a Pregnant Woman with Compound Sickle Cell Disease/β<sup>0</sup>-Thalassemia: Case Report and Review of the Literature